KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Procter & Gamble (PG) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Procter & Gamble (PG) over the last 17 years, with Q4 2025 value amounting to $10.8 billion.

  • Procter & Gamble's Cash & Equivalents rose 581.62% to $10.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $10.8 billion, marking a year-over-year increase of 581.62%. This contributed to the annual value of $9.6 billion for FY2025, which is 78.04% up from last year.
  • According to the latest figures from Q4 2025, Procter & Gamble's Cash & Equivalents is $10.8 billion, which was up 581.62% from $11.2 billion recorded in Q3 2025.
  • Procter & Gamble's 5-year Cash & Equivalents high stood at $12.2 billion for Q3 2024, and its period low was $6.7 billion during Q3 2022.
  • In the last 5 years, Procter & Gamble's Cash & Equivalents had a median value of $9.5 billion in 2024 and averaged $9.2 billion.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 4062.72% in 2022, then soared by 4505.22% in 2023.
  • Procter & Gamble's Cash & Equivalents (Quarter) stood at $11.5 billion in 2021, then plummeted by 40.63% to $6.9 billion in 2022, then grew by 15.12% to $7.9 billion in 2023, then grew by 29.66% to $10.2 billion in 2024, then rose by 5.82% to $10.8 billion in 2025.
  • Its Cash & Equivalents was $10.8 billion in Q4 2025, compared to $11.2 billion in Q3 2025 and $9.6 billion in Q2 2025.